Tweets
Great work from #CATCH cohort. Yes I am biased. @earlyarthritis #ACR21 abst#1661 @RheumNow https://t.co/hogyNEQiWM
Janet Pope @Janetbirdope ( View Tweet )
4 years 8 months ago
#Guselkimab Better than #ustekinumab for skin& MSK. #Ixekizumab beat ustekinumab for skin. #ustekinumab loses throne in #psoriasis and #psoriatic arthritis except maybe if concomitant inflammatory bowel disease post TNFi? Rapidly evolving PsA Rx. Abst#1773 #ACR21 @RheumNow https://t.co/Dkf2DFFsSK
Janet Pope @Janetbirdope ( View Tweet )
4 years 8 months ago
COVID 19 Poster Review
Abst 0197
Haibel & colleagues performed open label study on IL-1/IL-6 inhibitor combo
- Majority avoided mechanical ventilation (25/31)
- 2 pts died while on ECMO
- CT Chest findings improved 1 month after treatment
#ACR21 @RheumNow https://t.co/CIJR1Tx8St
Akhil Sood MD @AkhilSoodMD ( View Tweet )
4 years 8 months ago
Post-Hoc of the ASCORE trial showed the following b/l characteristics were most likely associated with remission (per DAS28, SDAI, CDAI) in mod-severe RA patients treated w/ SQ Abatacept:
⭐️Seropositivity
⭐️no prior bMDARD use
⭐️low HAQ-DI
⭐️low BMI
Abst#1228 @ACR21 @Rheumnow https://t.co/LRd1HVbm5B
Meral K. El Ramahi, MD @MeralElRamahiMD ( View Tweet )
4 years 8 months ago
CH COVID 19 Poster Review
Abst 0196
Jackson & colleagues performed double blind RCT of anakinra in patients with features of COVID-19 cytokine storm
- Anakinra + GC did not significantly impact outcomes in patients with cytokine storm syndrome
#ACR21 @RheumNow https://t.co/hX7bBtrIzT
Akhil Sood MD @AkhilSoodMD ( View Tweet )
4 years 8 months ago
All for one or one for all? Lumper or splitter? Highlight from #ACR21 was session 6S403 looking at axial involvement in AxSpa vs PsA. I share my thoughts here at https://t.co/i2nDvMklee @RheumNow https://t.co/62tRRiAcUJ
Dr. Antoni Chan @synovialjoints ( View Tweet )
4 years 8 months ago
Serious infections beyond herpes zoster in both doses of #tofacitinib v #TNFi in Oral Surveillance. Note this outcome was not powered to be stat sig. it is a comparison of SIE events #ACR21 abst#1684 @RheumNow https://t.co/uqME6ABXuC
Janet Pope @Janetbirdope ( View Tweet )
4 years 8 months ago
SLE Panel: Learning about Lupus
Drs. Kathryn Dao, Janet Pope, Yuz Yusof, Bella Mehta and Pedro Castillo discuss lupus-related data presented at #ACR21.
@KDAO2011 @Janetbirdope @Yuz6Yusof @bella_mehta @_Castillo_Pedro
https://t.co/RPl6ZqWS05 https://t.co/mdTyocBbr2
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 8 months ago
Gout being sneaky🧐
Common consult question is "infection or flare?" in patients with gout.
@ACR21 ABS0467 w/ Dr Michael Toprover:
🔸Calibrating DECT for LS-spine in gout patients.
🔹DECT signal = MSU deposition?
🔸Future data on back pain/gout flare/MSU🤞?
@RheumaRepublic https://t.co/aDCusqBk8G
Bonnia Liu @bonnialiu ( View Tweet )
4 years 8 months ago
Dr. Atul Deodhar with an excellent presentation on treatment in axSpA and axPsA. Note ustekinumab and risankizumab did not show improvement in axSpA. However, these studies did not include axPsA.
@ACR21 6S403 @RheumNow https://t.co/F73lvpF2at
Pedro Castillo @_Castillo_Pedro ( View Tweet )
4 years 8 months ago
More thoughts from @ashira_md's talk on Gaslighting/microaggressions from #ACR21 ...
(Q 1/2)
Providers: have you ever been told you are difficult and/or challenging?
Elizabeth Graef @SituationRheum ( View Tweet )
4 years 8 months ago
Abst 1661
Scheir & colleagues identified patterns of multimorbidity and association w/ disability in patients w/ early RA
- In women: Depression significantly associated w/ disability
- In men: HTN & Lung Disease significantly associated w/ disability
#ACR21 @RheumNow https://t.co/0qkn1TcvOi
Akhil Sood MD @AkhilSoodMD ( View Tweet )
4 years 8 months ago
